DiaGenic issues notification of trade among insiders

Download PDF Copy

Dec 20 2010

NewsGuard 100/100 Score

DiaGenic ASA (OSE:DIAG):

On 17 December 2010 mandatory notification of trade among insiders of DiaGenic ASA took place.

Henrik Lund, Chairman of the Board of DiaGenic ASA, has purchased 400,000 shares in DiaGenic ASA at a price of NOK 0.97 per share. After the transaction, Lund holds 400,000 shares in the Company.

Ingrid Wiik, Vice Chairman of the Board of DiaGenic ASA, has purchased 200,000 shares in DiaGenic ASA at an average price of NOK 0.925 per share. After the transaction, Wiik holds 200,000 shares in the Company.

This information is subject of the disclosure requirements acc. to §5-12 vphl (Norwegian Securities Trading Act).

Source:

DiaGenic ASA

Posted in:

Tags: Alzheimer's Disease, Biotechnology, Breast Cancer, Cancer, Gene, Gene Expression

Comments (0)

Download PDF Copy

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.

Post a new comment

Post

Hi, I'm Azthena, you can trust me to find commercial scientific answers from News-Medical.net.

To start a conversation, please log into your AZoProfile account first, or create a new account.

Registered members can chat with Azthena, request quotations, download pdf's, brochures and subscribe to our related newsletter content.

A few things you need to know before we start. Please read and accept to continue.

Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
Large Language Models can make mistakes. Consider checking important information.

I understand, and agree to receive occasional emails about Azthena such as usage tips and new feature announcements.

Please check the box above to proceed.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.